MedTrace Logo

Brain Health Virtual Reality Study

NCT06124339 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-07-10

No results posted yet for this study

Summary

The Interventions for Brain Health Virtual Reality Study is a NIH-funded clinical research trial at the University of California San Diego (UCSD) Health under the supervision of the study principal investigator Dr. Judy Pa. The overarching goal of this trial is to use a novel virtual reality (VR) based intervention that simultaneously engages physical and cognitive activity aimed at improving brain health and cognition in older adults. The investigators will compare 3 types of interventions: physical activity, VR cognitive activity, and combined VR physical and cognitive activity over 16 weeks to evaluate physical and brain health changes.

Conditions

  • Aging
  • Aging Problems
  • Memory Loss
  • Memory Impairment
  • Memory Disorders in Old Age
  • Memory Disorder, Spatial
  • Memory Disorders
  • Mild Cognitive Impairment
  • Cognitive Decline
  • Cognitive Change
  • Cognition Disorders in Old Age

Interventions

BEHAVIORAL

Physical Activity

There will be three sessions a week over the course of 16 weeks.

BEHAVIORAL

Cognitive Activity (VR)

There will be three sessions a week over the course of 16 weeks.

BEHAVIORAL

Physical and Cognitive Activity

There will be three sessions a week over the course of 16 weeks.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-08
Primary Completion
2028-08-08
Completion
2029-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06124339 on ClinicalTrials.gov